News | January 24, 2014

Radiation Before Surgery More Than Doubles Mesothelioma Survival

January 24, 2013 — Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants afflicted with this deadly disease, compared to treating with surgery first.
 
The Journal of Thoracic Oncology published the findings, which chart a route to treat patients effectively and improve their quality of life and potential survival, said principal investigator and lead author John Cho, M.D., radiation oncologist at Princess Margaret Cancer Centre, University Health Network (UHN). 
 
“The patients in our study experienced shorter treatment, fewer complications and speedier recovery,” Dr. Cho said. “The three-year survival rate more than doubled to 72 percent from 32 percent.” 
 
Mesothelioma is an aggressive malignancy that starts in the lining of the lung and progressively restricts and invades the whole organ. The study assessed Surgery for Mesothelioma After Radiation Therapy (SMART), which was completed over four years with 25 patients who underwent radiation therapy at Princess Margaret Cancer Centre and surgery at Toronto General Hospital, both part of UHN.
 
Participants were treated with an accelerated, five-day course of intensity-modulated radiation therapy (IMRT), a specialized technique that conforms the radiation dose around the tumors in 3-D while sparing the heart, spine and other healthy tissues. Patients’ affected lungs were removed the following week. 
 
The SMART approach reduced the treatment cycle for patients to one month from five months and reduced the risk of recurrence because radiation prevented the cancer from seeding elsewhere in the chest or abdomen during surgery.
 
Exposure to asbestos is the main cause of mesothelioma in the 500 new cases reported in Canada each year.
 
For more information: www.theprincessmargaret.ca, www.uhn.ca

Related Content

Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...
Dynamic Digital Radiography Used to Assess Undifferentiated Dyspnea
News | Digital Radiography (DR) | May 29, 2019
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described...
Leica Biosystems Receives FDA Clearance for Aperio AT2 DX Digital Pathology System
Technology | Digital Pathology | May 29, 2019
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin